Related references
Note: Only part of the references are listed.miR-320b suppresses cell proliferation by targeting c-Myc in human colorectal cancer cells
Hantao Wang et al.
BMC CANCER (2015)
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan Robinson et al.
CELL (2015)
MicroRNA-449a Inhibits Proliferation and Induces Apoptosis by Directly Repressing E2F3 in Gastric Cancer
Xiaoping Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
MicoRNA-451 is a novel tumor suppressor via targeting c-myc in head and neck squamous cell carcinomas
Huimin Wang et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2015)
microRNA-449a functions as a tumor suppressor in neuroblastoma through inducing cell differentiation and cell cycle arrest
Zhenze Zhao et al.
RNA BIOLOGY (2015)
MYC and metabolism on the path to cancer
Annie L. Hsieh et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2015)
MicroRNA Processing and Human Cancer
Masahisa Ohtsuka et al.
JOURNAL OF CLINICAL MEDICINE (2015)
MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein
Yilong Yao et al.
MOLECULAR ONCOLOGY (2015)
MicroRNA-130a associates with ribosomal protein L11 to suppress c-Myc expression in response to UV irradiation
Yuhuang Li et al.
ONCOTARGET (2015)
Conversion of Androgen Receptor Signaling From a Growth Suppressor in Normal Prostate Epithelial Cells to an Oncogene in Prostate Cancer Cells Involves a Gain of Function in c-Myc Regulation
Donald J. Vander Griend et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)
MiR-449a functions as a tumor suppressor in endometrial cancer by targeting CDC25A
Wenwei Ye et al.
ONCOLOGY REPORTS (2014)
MYC Regulation of CHK1 and CHK2 Promotes Radioresistance in a Stem Cell-like Population of Nasopharyngeal Carcinoma Cells
Wen-Jun Wang et al.
CANCER RESEARCH (2013)
miRNA profiling of cancer
Gianpiero Di Leva et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2013)
Amplitude modulation of androgen signaling by c-MYC
Min Ni et al.
GENES & DEVELOPMENT (2013)
MicroRNA-449a Is Downregulated in Non-Small Cell Lung Cancer and Inhibits Migration and Invasion by Targeting c-Met
Wenting Luo et al.
PLOS ONE (2013)
Radiosensitization in prostate cancer: mechanisms and targets
Diego A. Palacios et al.
BMC UROLOGY (2013)
Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivity
Luqing Zhao et al.
CARCINOGENESIS (2012)
c-Myc down-regulation is involved in proteasome inhibitor-mediated enhancement of radiotherapeutic efficacy in non-small cell lung cancer
Joohee Jung et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
MicroRNA-34a Modulates c-Myc Transcriptional Complexes to Suppress Malignancy in Human Prostate Cancer Cells
Soichiro Yamamura et al.
PLOS ONE (2012)
MYC Is Activated by USP2a-Mediated Modulation of MicroRNAs in Prostate Cancer
Barbara Benassi et al.
CANCER DISCOVERY (2012)
Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells
Paivi Ostling et al.
CANCER RESEARCH (2011)
Survivin regulation by HER2 through NF-κB and c-myc in irradiated breast cancer cells
Vassilis Papanikolaou et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
miR-449 inhibits cell proliferation and is down-regulated in gastric cancer
Tony Bou Kheir et al.
MOLECULAR CANCER (2011)
Phosphorylation and stabilization of c-Myc by NEMO renders cells resistant to ionizing radiation through up-regulation of γ-GCS
Bu-Yeon Kim et al.
ONCOLOGY REPORTS (2011)
MicroRNA-Mediated Processes are Essential for the Cellular Radiation Response
Anne Kraemer et al.
RADIATION RESEARCH (2011)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC
N. R. Christoffersen et al.
CELL DEATH AND DIFFERENTIATION (2010)
p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication
Ian G. Cannell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence
D. Hawksworth et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2010)
miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression
T. Murata et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2010)
miR-21: An Androgen Receptor-Regulated MicroRNA that Promotes Hormone-Dependent and Hormone-Independent Prostate Cancer Growth
Judit Ribas et al.
CANCER RESEARCH (2009)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
miR-449a and miR-449b are direct transcriptional targets of E2F1 and negatively regulate pRb-E2F1 activity through a feedback loop by targeting CDK6 and CDC25A
Xiaojing Yang et al.
GENES & DEVELOPMENT (2009)
miR-449a targets HDAC-1 and induces growth arrest in prostate cancer
E. J. Noonan et al.
ONCOGENE (2009)
p53 represses c-Myc through induction of the tumor suppressor miR-145
Mohit Sachdeva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Facilitating replication under stress: an oncogenic function of MYC?
Steffi Herold et al.
NATURE REVIEWS CANCER (2009)
Molecular Alterations in Prostate Cancer as Diagnostic, Prognostic, and Therapeutic Targets
Bora Gurel et al.
ADVANCES IN ANATOMIC PATHOLOGY (2008)
Targeting the androgen receptor pathway in prostate cancer
Yu Chen et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells
Xu-Bao Shi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Prediction and preliminary validation of oncogene regulation by miRNAs
Edyta Koscianska et al.
BMC MOLECULAR BIOLOGY (2007)
Myc goes global: New tricks for an old oncogene
Paul S. Knoepfler
CANCER RESEARCH (2007)
The Myc oncoprotein as a therapeutic target for human cancer
Marina Vita et al.
SEMINARS IN CANCER BIOLOGY (2006)
8q gain is an independent predictor of poor survival in diagnostic needle biopsies from prostate cancer suspects
Franclim R. Ribeiro et al.
CLINICAL CANCER RESEARCH (2006)
Design of shRNAs for RNAi - A lesson from pre-miRNA processing: Possible clinical applications
V Pekarik
BRAIN RESEARCH BULLETIN (2005)
Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype
K Williams et al.
PROSTATE (2005)
Molecular markers of prostate cancer outcome
DI Quinn et al.
EUROPEAN JOURNAL OF CANCER (2005)
Role of cell cycle in mediating sensitivity to radiotherapy
TM Pawlik et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance
J Holzbeierlein et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints
H Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer
N Tsuchiya et al.
GENES CHROMOSOMES & CANCER (2002)
Share Paper
